Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,349.00
+41.00 (3.13%)
Jun 18, 2025, 5:24 PM IDT
9.23%
Market Cap 153.98M
Revenue (ttm) 308.19M
Net Income (ttm) 2.60M
Shares Out 11.41M
EPS (ttm) 0.22
PE Ratio 61.04
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 163
Average Volume 819
Open 1,308.00
Previous Close 1,308.00
Day's Range 1,308.00 - 1,349.00
52-Week Range 1,130.00 - 1,601.00
Beta 0.11
RSI 50.58
Earnings Date May 26, 2025

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in... [Read more]

Sector Healthcare
Founded 1947
Employees 421
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.